Assessing the implementation effectiveness and safety of 1% tenofovir gel provision through family planning services in KwaZulu-Natal, South Africa: study protocol for an open-label randomized controlled trial

BACKGROUND: The Centre for the AIDS Programme of Research in South Africa (CAPRISA) 004 trial demonstrated a 39% reduction in HIV infection, with a 54% HIV reduction in women who used tenofovir gel consistently. A confirmatory trial is expected to report results in early 2015. In the interim, we hav...

Descripción completa

Detalles Bibliográficos
Autores principales: Mansoor, Leila E, Abdool Karim, Quarraisha, Mngadi, Kathryn T, Dlamini, Sarah, Montague, Carl, Nkomonde, Nelisiwe, Mvandaba, Nomzamo, Baxter, Cheryl, Gengiah, Tanuja N, Samsunder, Natasha, Dawood, Halima, Grobler, Anneke, Frohlich, Janet A, Abdool Karim, Salim S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4300828/
https://www.ncbi.nlm.nih.gov/pubmed/25527071
http://dx.doi.org/10.1186/1745-6215-15-496

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4300828/
https://www.ncbi.nlm.nih.gov/pubmed/25527071
http://dx.doi.org/10.1186/1745-6215-15-496

Ejemplares similares